Mesenchymale Stammzellen beeinflussen das Transplantatüberleben unterschiedlich in Abhängigkeit einer immunsuppressiven Therapie
Felix Popp(University of Regensburg), M.H. Dahlke(University of Regensburg), Jonas Steinmann(University of Regensburg), Pompiliu Piso(Krankenhaus Barmherzige Brüder), Elke Eggenhofer(University Hospital Regensburg), Philipp Renner(Robert Bosch Hospital), Hans J. Schlitt(University Hospital Regensburg)
Cited by 0
Related Papers
Right Portal Vein Ligation Combined With In Situ Splitting Induces Rapid Left Lateral Liver Lobe Hypertrophy Enabling 2-Staged Extended Right Hepatic Resection in Small-for-Size Settings
|Annals of Surgery|2012|1.3k
Banff Schema for Grading Liver Allograft Rejection: An International Consensus Document
|Hepatology|1997|1.3k
Mesenchymal stem cells are short-lived and do not migrate beyond the lungs after intravenous infusion
|Frontiers in Immunology|2012|820
Regulatory cell therapy in kidney transplantation (The ONE Study): a harmonised design and analysis of seven non-randomised, single-arm, phase 1/2A trials
|The Lancet|2020|445
Biomarker-guided Intervention to Prevent Acute Kidney Injury After Major Surgery
|Annals of Surgery|2017|378